kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the HEPA dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for HEPA.

HEPA

Hepion Pharmaceuticals, Inc.
Healthcare · Biotechnology
$292.96 sample
-1.39 (-0.47%) 1D
☆ Watch
Market cap
$820.5B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-21
Alerts
8
Price$292.96 +4.15% 3M daily closessample
314.43281.29
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 21SEC10-Q filed
  • Oct 13INSInsider buy: EVP, Operations
  • Oct 07SEC10-Q filed
  • Oct 01INSInsider buy: EVP, Operations
  • Sep 22INSInsider sell: Director
  • Sep 17INSInsider buy: 10% owner
  • Sep 09INSInsider buy: 10% owner
  • Sep 02INSInsider buy: Chief Financial Officer
Sign up to see the real HEPA record →

Company facts

SEC EDGAR registration
Name
Hepion Pharmaceuticals, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
-48sample, -100 to +100
Reporting currency
USD

Who is positioning in HEPA

sample
Insiders
29 insider transactions over 90 days, net selling, $556.3M
Congress
2 members traded over 90 days
Institutions · 13F
43 funds hold $19.1B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$23.9B +23.0% y/y
Q4 2024Q3 2026
Inventory$14.2B +12.0% y/y
Q4 2024Q3 2026
Accounts receivable$10.0B +5.8% y/y
Q4 2024Q3 2026
Total debt$27.4B +13.6% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$745.2B -12.1% 3M
Sample peer B
$705.5B +15.4% 3M
Sample peer C
$327.9B +2.9% 3M
Sample peer D
$92.5B +0.0% 3M
Sample peer E
$228.1B +7.1% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not HEPA's real figure. Nothing here is investment advice.